ArticleChina CDC weekly2026
Epidemiological Characteristics of Asymptomatic Tuberculosis - China, 2021-2024.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Tuberculosis (TB) remains a major public health challenge in China, which ranks fourth among the 30 high-burden countries worldwide. Individuals with asymptomatic Pulmonary TB (aPTB) may act as "silent transmitters", contributing to undetected community transmission and hindering progress toward the End-TB goals. This study examined the epidemiological characteristics of patients with aPTB in China from 2021 to 2024 to inform targeted control strategies. Methods: Data were obtained from the China Information System for Disease Control and Prevention for the period 2021-2024 and included TB cases with complete symptom records. aPTB was defined as cases without recorded cough symptoms, whereas symptomatic TB was defined as cases with recorded cough symptoms. Descriptive statistical analyses compared the demographic, clinical, and healthcare-seeking characteristics of patients with aPTB and symptomatic TB. Results: Among 973,299 PTB cases with complete symptom records, 16.66% were classified as aPTB. This proportion remained relatively stable throughout the study period, with a slight peak observed in 2022. Higher proportions of aPTB were observed among individuals aged 55-64 years (17.07%), 65-74 years (15.51%), and 15-24 years (14.03%), and among farmers and herders (50.87%). A mild seasonal trend was observed. Geographically, high-incidence areas were concentrated in western and southwestern China. Conclusions: aPTB constitutes a substantial component of the total TB burden in China. Strengthening active case detection in high-risk populations, optimizing medical resources in western China, and integrating aPTB control programs into national prevention and control plans for TB to mitigate hidden transmissions and advance national End-TB objectives.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.